These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 17431760
1. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Verkooijen HM, Koot VC, Fioretta G, van der Heiden M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C. Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760 [Abstract] [Full Text] [Related]
2. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva. Bouchardy C, Usel M, Verkooijen HM, Fioretta G, Benhamou S, Neyroud-Caspar I, Schaffar R, Vlastos G, Wespi Y, Schäfer P, Rapiti E. Breast Cancer Res Treat; 2010 Apr; 120(2):519-23. PubMed ID: 19633953 [Abstract] [Full Text] [Related]
3. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy. Bouchardy C, Morabia A, Verkooijen HM, Fioretta G, Wespi Y, Schäfer P. BMC Cancer; 2006 Mar 22; 6():78. PubMed ID: 16551373 [Abstract] [Full Text] [Related]
4. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Jemal A, Ward E, Thun MJ. Breast Cancer Res; 2007 Mar 22; 9(3):R28. PubMed ID: 17477859 [Abstract] [Full Text] [Related]
5. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation. Crocetti E, Buzzoni C, Falcini F, Cortesi L, De Lisi V, Ferretti S, Tumino R, Russo A, Paci E. Breast J; 2010 Mar 22; 16(4):350-5. PubMed ID: 20443789 [Abstract] [Full Text] [Related]
6. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM. Cancer Epidemiol Biomarkers Prev; 2004 Oct 22; 13(10):1569-73. PubMed ID: 15466971 [Abstract] [Full Text] [Related]
7. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Cancer Causes Control; 2010 Feb 22; 21(2):275-82. PubMed ID: 19894130 [Abstract] [Full Text] [Related]
8. [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend]. Allemand H, Seradour B, Weill A, Ricordeau P. Bull Cancer; 2008 Jan 22; 95(1):11-5. PubMed ID: 18230565 [Abstract] [Full Text] [Related]
9. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years. Taylor R, Page A, Bampton D, Estoesta J, Rickard M. J Med Screen; 2004 Jan 22; 11(4):199-206. PubMed ID: 15563775 [Abstract] [Full Text] [Related]
10. Breast cancer incidence after the introduction of mammography screening: what should be expected? Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Cancer; 2006 May 01; 106(9):1883-90. PubMed ID: 16572411 [Abstract] [Full Text] [Related]
11. HRT and breast cancer: impact on population risk and incidence. Coombs NJ, Taylor R, Wilcken N, Boyages J. Eur J Cancer; 2005 Aug 01; 41(12):1775-81. PubMed ID: 16087330 [Abstract] [Full Text] [Related]
12. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg. Vankrunkelsven P, Kellen E, Lousbergh D, Cloes E, Op de Beeck L, Faes C, Bruckers L, Mertens R, Coebergh JW, Van Leeuwen FE, Buntinx F. Breast Cancer Res Treat; 2009 Nov 01; 118(2):425-32. PubMed ID: 19238536 [Abstract] [Full Text] [Related]
13. Mammography screening and the increase in breast cancer incidence in Hawaii. Maskarinec G, Wilkens L, Meng L. Cancer Epidemiol Biomarkers Prev; 1997 Mar 01; 6(3):201-8. PubMed ID: 9138664 [Abstract] [Full Text] [Related]
14. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV. Breast Cancer Res Treat; 2009 May 01; 115(1):181-3. PubMed ID: 18516674 [Abstract] [Full Text] [Related]
15. [Results of preventive mammography before initiation of hormone replacement therapy]. Kichukova D, Kichukov K, Khristov R, Velevski V. Akush Ginekol (Sofiia); 2003 May 01; 42 Suppl 2():28-30. PubMed ID: 14619752 [Abstract] [Full Text] [Related]
16. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M. Maturitas; 2009 Oct 20; 64(2):80-5. PubMed ID: 19709827 [Abstract] [Full Text] [Related]
17. Impact of hormone replacement therapy on the histologic subtype of breast cancer. Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E. Arch Gynecol Obstet; 2008 Nov 20; 278(5):443-9. PubMed ID: 18335229 [Abstract] [Full Text] [Related]
18. Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation. El Saghir NS, Shamseddine AI, Geara F, Bikhazi K, Rahal B, Salem ZM, Taher A, Tawil A, El Khatib Z, Abbas J, Hourani M, Seoud M. J Med Liban; 2002 Nov 20; 50(1-2):3-9. PubMed ID: 12841305 [Abstract] [Full Text] [Related]
19. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Ji J, Hemminki K. Breast Cancer Res Treat; 2007 Oct 20; 105(2):229-36. PubMed ID: 17115107 [Abstract] [Full Text] [Related]
20. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Katalinic A, Rawal R. Breast Cancer Res Treat; 2008 Feb 20; 107(3):427-30. PubMed ID: 17453336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]